MYC and cancer: Further, GSVA unraveled that many cancer hallmarks were dysregulated between these two groups (Figure 1C), with a noticeable pattern of an enrichment of proliferation pathways (e.g. E2F targets, G2M checkpoint and MYC targets) in the mutant group.